Gulf International Bank (UK)’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,637
Closed -$399K 685
2023
Q2
$399K Sell
9,637
-2,855
-23% -$177K 0.01% 621
2023
Q1
$751K Sell
12,492
-4,350
-26% -$348K 0.02% 593
2022
Q4
$1.24M Hold
16,842
0.02% 556
2022
Q3
$1.28M Hold
16,842
0.02% 536
2022
Q2
$1.22M Hold
16,842
0.02% 555
2022
Q1
$1.4M Hold
16,842
0.02% 552
2021
Q4
$1.26M Sell
16,842
-4,000
-19% -$402K 0.02% 581
2021
Q3
$2.42M Hold
20,842
0.03% 498
2021
Q2
$4.62M Buy
20,842
+980
+5% +$191K 0.06% 332
2021
Q1
$2.63M Sell
19,862
-2,194
-10% -$347K 0.04% 473
2020
Q4
$3.82M Buy
+22,056
New +$3.02M 0.05% 364

Other funds holding NVCR

Gulf International Bank (UK)'s NVCR Position: Q3 2023 in Review

Gulf International Bank (UK) sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 9,637 shares — an estimated $399K sold.

Gulf International Bank (UK) first reported a position in NVCR in Q4 2020 and held it in 11 quarters. The position peaked at $4.62M in Q2 2021. 227 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Gulf International Bank (UK) reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Gulf International Bank (UK) sold 9,637 NovoCure shares in Q3 2023, an estimated $399K.
  • Gulf International Bank (UK) first reported a position in NovoCure in Q4 2020 and held it in 11 quarters.
  • Gulf International Bank (UK)'s NovoCure position peaked at $4.62M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Gulf International Bank (UK)'s 13F filing for Q3 2023, filed 10 Oct 2023.